References
- Davies G, Paton JY, Beaton SJ, et al. Children admitted with acute
wheeze/asthma during November 1998-2005: a national UK audit. Arch Dis
Child 2008; 93: 952–8
- Bloom CI, Nissen F, Douglas IJ, et al. Exacerbation risk and
characterisation of the UK’s asthma population from infants to old
age. Thorax 2018; 73: 313–20
- Brand PLP, Baraldi E, Bisgaard H, et al. Definition, assessment and
treatment of wheezing disorders in preschool children: an
evidence-based approach. Eur Respir J 2008; 32: 1096–110
- Makrinioti H, Klaber R, Watson M. Around the world: preschool wheeze.
Lancet Respir Med. 2017; 5: 688-689
- Bush A, Pavord ID. ’We can’t diagnose asthma until <insert
arbitrary age>’. Arch Dis Child. 2018; 103: 729-731
- Pavord ID, Beasley R, Agusti A,
Anderson GP, Bel E, Brusselle G, et al. After asthma –
redefining airways diseases. A Lancet commission. Lancet 2018;
391: 350-400
- Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, pet
al. Treatable traits: toward precision medicine of chronic airway
diseases. Eur Respir J. 2016; 47: 410-9.
- Mallol J, García-Marcos L, Solé D, Brand P; EISL Study Group.
International prevalence of recurrent wheezing during the first year
of life: variability, treatment patterns and use of health resources.
Thorax. 2010; 65: 1004-9.
- Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and
inflammation in symptomatic infants with reversible airflow
obstruction. Am J Respir Crit Care Med. 2005; 171: 722-727.
- Cane RS, McKenzie SA. Parents’ interpretations of
children’s respiratory symptoms on video. Arch Dis Child. 2001; 84:
31-34.
- Turner S, Custovic A, Ghazal P, Grigg J, Gore M, Henderson J, et al.
Pulmonary epithelial barrier and immunological functions at birth and
in early life - key determinants of the development of asthma? A
description of the protocol for the Breathing Together study. Wellcome
Open Res 2018; 3: 60
- Levy ML, Godfrey S, Irving CS, Sheikh A, Hanekom W, Ambulatory Care
Nurses, Bush A, Lachman P. Wheeze detection in infants and
pre-school children: recordings versus assessment of physician and
parent. J Asthma 2004; 41: 845-853
- Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB.
Evaluation and outcome of young children with chronic cough. Chest.
2006; 129: 1132-41.
- Chang AB, Bush A, Grimwood K. Bronchiectasis in children. Lancet 2018;
392: 866-879
- Chang AB, Fortescue R, Grimwood
K, Alexopoulou E, Bell B, Boyd J, Bush A, et al . Task Force
report: European Respiratory Society guidelines for the management of
children and adolescents with bronchiectasis. Eur Respir J 2021; 58:
2002990
- Bush A. Persistent
Bacterial Bronchitis: Time to Venture beyond the Umbrella. Front.
Pediatr., https://doi.org/10.3389/fped.2017.00264
- Bush A. Diagnosis of asthma in children under five. Prim Care Respir
J. 2007; 16: 7-15
- Thompson M, Vodicka TA, Blair PS, Buckley DI, Heneghan C, Hay
AD; TARGET Programme Team. Duration of symptoms of respiratory tract
infections in children: systematic review. BMJ. 2013; 347: f7027.
- Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled
corticosteroids in preschool children at high risk for asthma. N Engl
J Med 2006; 354: 1985-7
- Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A; IFWIN study
team. Secondary prevention of asthma by the use of Inhaled Fluticasone
propionate in Wheezy INfants (IFWIN): double-blind, randomised,
controlled study. Lancet. 2006; 368: 754-62.
- Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F.
Intermittent inhaled corticosteroids in infants with episodic
wheezing. N Engl J Med. 2006; 354: 1998-2005.
- O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators
Group. Severe exacerbations and decline in lung function in asthma. Am
J Respir Crit Care Med. 2009; 179: 19-
- Kotaniemi-Syrjänen A, Klemola T, Koponen P, Jauhola O, Aito H,
Malmström K, et al. Intermittent Tiotropium Bromide for Episodic
Wheezing: A Randomized Trial. Pediatrics. 2022; 150: e2021055860.
- Saglani S, Bingham Y, Balfour-Lynn I, Goldring S, Gupta A, Banya W,
Moreiras J, Fleming L, Bush A, Rosenthal M. Blood eosinophils in
managing preschool wheeze: Lessons learnt from a proof-of-concept
trial. Pediatr Allergy Immunol. 2022; 33: e13697
- Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil
activation and cysteinyl leukotriene production in
infants with respiratory syncytial virus bronchiolitis. Clin Exp
Allergy. 2004; 34: 555-8AJRCCM 207; 175: 323-9
- Robertson CF, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D, Lee
AJ, Turner J, Sant M. Short-course montelukast for intermittent asthma
in children: a randomized controlled trial. Am J Respir Crit Care Med.
2007; 175: 323-9.
- Bacharier LB, Phillips BR, Zeiger RS, et al; CARE Network. Episodic
use of an inhaled corticosteroid or leukotriene receptor antagonist in
preschool children with moderate-to-severe intermittent wheezing. J
Allergy Clin Immunol 2008; 122: 1127-35
- Valovirta E, Boza ML, Robertson CF, et al. Intermittent or daily
montelukast versus placebo for episodic asthma in children. Ann
Allergy Asthm Immunol 2011; 106: 518-26
- Nwokoro C, Pandya H, Turner S, et al. Intermittent montelukast in
children aged 10 months to 5 years with wheeze (WAIT trial): a
multicentre, randomised, placebo-controlled trial. Lancet Respir Med
2014; 2: 796-803
- Benard B, Bastien V, Vinet B, Yang R, Krajinovic M, Ducharme FM.
Neuropsychiatric adverse drug reactions in children initiated on
montelukast in real-life practice. Eur Respir J. 2017; 50: 1700148.
- Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung
disease. Pediatr Pulmonol 2001; 31: 464-473.
- Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in
the subset of common-cold patients who have bacteria in nasopharyngeal
secretions. Lancet 1996; 347: 1507-10
- Bisgaard H, Hermansen MN, Bønnelykke K, Stokholm J, Baty F, Skytt NL,
Aniscenko J, Kebadze T, Johnston SL. Association of bacteria and
viruses with wheezy episodes in young children: prospective birth
cohort study. BMJ 2010; 341: c4978
- Stokholm J, Chawes BL, Vissing NH, et al. Azithromycin for episodes
with asthma-like symptoms in young children aged 1-3 years: a
randomised, double-blind, placebo-controlled trial. Lancet Respir Med
2016; 4: 19-26
- Bacharier LB, Guilbert TW, Mauger DT, Boehmer S, Beigelman A,
Fitzpatrick AM, Jackson DJ, et al. Early Administration
of Azithromycin and Prevention of Severe Lower Respiratory Tract
Illnesses in Preschool Children With a History of Such Illnesses: A
Randomized Clinical Trial. .JAMA. 2015; 314: 2034-2044.
- Mandhane PJ, Paredes Zambrano de Silbernagel P, Aung YN, Williamson J,
Lee BE, Spier S, Noseworthy M, Craig WR, Johnson DW. Treatment of
preschool children presenting to the emergency department with wheeze
with azithromycin: A placebo-controlled randomized trial. PLoS One.
2017; 12: e0182411.
- Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong
L, Chen C, Cook C, Lebas E, O’Brien KS, Oldenburg CE, Chow ED, Porco
TC, Lipsitch M, Keenan JD, Lietman TM. Macrolide and
Nonmacrolide Resistance with Mass Azithromycin Distribution. N Engl J
Med. 2020; 383: 1941-1950.
- Wilson N, Sloper K, Silverman M. Effect of continuous treatment with
topical corticosteroid on episodic viral wheeze in preschool children.
Arch Dis Child. 1995; 72: 317-20.
- Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose
fluticasone for virus-induced wheezing in young children. NEJM 2009;
360: 339-53
- Zeiger RS, Mauger D, Bacharier LB, et al; CARE Network of the National
Heart, Lung, and Blood Institute. Daily or intermittent budesonide in
preschool children with recurrent wheezing. N Engl J Med 2011; 365:
1990-2001
- Brand PL, Caudri D, Eber E, Gaillard EA, Garcia-Marcos L, Hedlin G,
Henderson J, Kuehni CE, Merkus PF, Pedersen S, Valiulis A, Wennergren
G, Bush A. Classification and pharmacological treatment of preschool
wheezing: changes since 2008. Eur Respir J. 2014; 43: 1172-7.
- Oommen A, Lambert PC, Grigg J. Efficacy of a short course of
parent-initiated oral prednisolone for viral wheeze in children aged
1-5 years: randomised controlled trial. Lancet. 2003; 362: 1433-8.
- Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth
A, Grigg J. Oral prednisolone for preschool children with acute
virus-induced wheezing. N Engl J Med. 2009; 360: 329-38.
- Castro-Rodriguez JA, Beckhaus AA, Forno E. Efficacy of oral
corticosteroids in the treatment of acute wheezing episodes in
asthmatic preschoolers: Systematic review with meta-analysis. Pediatr
Pulmonol. 2016; 51: 868-76.
- Foster SJ, Cooper MN, Oosterhof O, Borland ML. Oral prednisolone in
preschool children with virus-associated wheeze: a prospective,
randomised, double-blind, placebo-controlled trial. Lancet Respir
Med. 2018; 6: 97-106.
- Saglani S, Rosenthal M, Bush A. Should oral corticosteroids be
prescribed for pre-school wheeze? Lancet Respir Med 2018; 6: e21
- Bush A, Saglani S. Medical Algorithm: Diagnosis and Treatment of
Pre-school Asthma. Allergy. 2200; 75: 2711-2712
- Jochmann A, Artusio L, Robson K, Nagakumar P, Collins N, Fleming
L, Bush A, Saglani S. Infection and inflammation in induced sputum
from preschool children with chronic airways diseases. Pediatr
Pulmonol. 2016; 51: 778-86
- Fitzpatrick AM, Jackson DJ,
Mauger DT, Boehmer SJ, Phipatanakul W, Sheehan WJ; NIH/NHLBI
AsthmaNet. Individualized therapy for persistent asthma in young
children. J Allergy Clin Immunol. 2016; 138: 1608-1618
- Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Sputum
inflammatory phenotypes are not stable in children with asthma.
Thorax. 2012; 67: 675-81.
- Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A,
et al. Management of severe asthma: a European Respiratory
Society/American Thoracic Society guideline. Eur Respir J. Eur Respir
J. 2020; 55: 1900588.
- Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH,
Agusti A, Studnicka M, Wouters EFM, Breyer-Kohansal R. Blood
eosinophil count in the general population: typical values and
potential confounders. Eur Respir J. 2020; 55: 1901874.
- Fitzpatrick AM, Grunwell JR, Cottrill KA, Mutic AD, Mauger DT. Blood
Eosinophils for Prediction of Exacerbation in Preschool Children With
Recurrent Wheezing. .J Allergy Clin Immunol Pract. 2023:
S2213-2198(23)00123-X.
- Couillard S, Laugerud A, Jabeen M, Ramakrishnan S, Melhorn J, Hinks
T, Pavord I. Derivation of a prototype asthma attack risk scale
centred on blood eosinophils and exhaled nitric oxide. Thorax. 2022;
77: 199-202.
- Robinson PFM, Pattaroni C, Cook J, Gregory L, Alonso AM, Fleming LJ,
Lloyd CM, Bush A, Marsland BJ, Saglani S. Lower airway microbiota
associates with inflammatory phenotype in severe preschool wheeze. J
Allergy Clin Immunol. 2019; 143: 1607-1610.
- Robinson PFM, Fontanella S, Ananth S, Martin Alonso A, Cook J, Kaya-de
Vries D, Polo Silveira L, Gregory L, Lloyd C, Fleming L, Bush A,
Custovic A, Saglani S. Recurrent Severe Preschool Wheeze: From
Pre-Specified Diagnostic Labels to Underlying Endotypes. Am J Respir
Crit Care Med. 2021; 204: 523-53
- Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM,
et al; investigators for the MRC Refractory Asthma Stratification
Programme. Composite type-2 biomarker strategy versus a
symptom-risk-based algorithm to adjust corticosteroid dose in patients
with severe asthma: a multicentre, single-blind, parallel group,
randomised controlled trial. Lancet Respir Med. 2021; 9: 57-68.
- Makrinioti H, Bush A, Griffiths C. What are patient-reported outcomes
and why they are important: improving studies of preschool wheeze
- Zeiger RS, Mellon M, Chipps B, et al. Test for respiratory and asthma
control in kids (track): clinically meaningful changes in score. J
Allergy Clin Immunol 2011; 128: 983–8.
- Seid M, Limbers CA, Driscoll KA, et al. Reliability, validity, and
responsiveness of the pediatric quality of life inventory (PedsQL)
generic core scales and asthma symptoms scale in vulnerable children
with asthma. J Asthma 2010; 47: 170-7
- Varni JW, Burwinkle TM, Rapoff MA , et al. The PedsQL in pediatric
asthma: reliability and validity of the pediatric quality of life
inventory generic core scales and asthma module. J Behav Med 2004; 27:
297–318.
- Ducharme FM, Jensen ME, Mendelson MJ , et al. Asthma flare-up diary
for young children to monitor the severity of exacerbations. J Allergy
Clin Immunol 2016; 137: 744–9
- Jensen ME, Mendelson MJ, Desplats E, et al. Caregiver’s functional
status during a young child’s asthma exacerbation: a validated
instrument. J Allergy Clin Immunol 2016; 137: 782–8.
Table1 Examples of treatable traits in pre-school wheeze
[based on reference 7]